1
Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: preliminary results
Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: preliminary results
Saturday, March 28, 2015: 7:55 AM
International Ballroom (Hilton Chicago)